EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors

Meizi Liu, Ran An, Zitong Wu, Leping Dai, Qiaomiao Zeng, Wenfeng Chen iD

Ear, Nose & Throat Journal · 2025

DOI: 10.1177/01455613241228211 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Ear, Nose & Throat Journal, 2025. Verfasst von Meizi Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Teaching and Research Section of Clinical Nursing, Xiangya Hospital Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Stomatitis, Radiation Injuries, Radiotherapy. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hunan Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Oral mucositis (OM) is a common and severe side effect of radiotherapy in head and neck cancer (HNC). The study aimed to investigate the longitudinal changes in OM and its influencing factors in patients with HNC during radiotherapy.

Methods

This was a retrospective longitudinal observational study. From July 2022 to March 2023, patients with HNC undergoing radiation therapy were enrolled. OM, oral hygiene, oral infections, oral pain, feeding route, and laboratory indicators were measured at 7 times. The influencing factors of OM were analyzed using generalized estimation equations (GEEs).

Results

A total of 160 patients were included in this study. The prevalence of severe OM at T0, T1, T2, T3, T4, T5, and T6 was 0, 0, 2.5%, 9.4%, 26.9%, 24.4%, and 26.9%, respectively. The prevalence of grade 1-2 OM at T0, T1, T2, T3, T4, T5, and T6 was 0, 16.3%, 53.1%, 65.1%, 61.9%, 70.7%, and 71.3%, respectively. Duration of diagnosis, clinical stage, N stage, M stage, surgery, diabetes, radiotherapy dose, oral hygiene, oral infection, oral pain, feeding route, and lymphocyte impacted OM significantly in the GEEs multivariate model.

Conclusions

OM occurs in almost all patients with HNC who undergo radiotherapy. Changes in the severity of OM are a dynamic process, with the severity increasing with the cumulative radiotherapy dose. Specialist oral evaluation and oral care are needed to alleviate the severity of OM in HNC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsStomatitisRadiation InjuriesRadiotherapyHumansMaleRetrospective StudiesFemaleMiddle AgedLongitudinal StudiesAgedPrevalenceAdultRisk FactorsSeverity of Illness IndexOral Hygiene

Stichwörter der Autor:innen

head and neck neoplasmslongitudinal studyoral mucositisradiotherapy

Autor:innen und Institutionen

  • Teaching and Research Section of Clinical Nursing, Xiangya Hospital Central South University, Changsha, Hunan, China.
  • Xiang Ya Nursing School, Central South University, Changsha, Hunan, China.

ORCID-Profile: Wenfeng Chen

Förderung

  • Hunan Provincial Health Commission

Zitieren

APA

Liu, M., An, R., Wu, Z., Dai, L., Zeng, Q., & Chen, W. (2025). The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors. Ear, Nose & Throat Journal. https://doi.org/10.1177/01455613241228211

Vancouver

Liu M, An R, Wu Z, Dai L, Zeng Q, Chen W. The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors. Ear, Nose & Throat Journal. 2025. doi:10.1177/01455613241228211

BibTeX
@article{Liu2025,
  author = {Liu, Meizi and An, Ran and Wu, Zitong and Dai, Leping and Zeng, Qiaomiao and Chen, Wenfeng},
  title = {The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and its Influencing Factors},
  journal = {Ear, Nose & Throat Journal},
  year = {2025},
  doi = {10.1177/01455613241228211}
}
Kostenlos starten →